ABBV shortABBV looks like a great setup 1W OB rejection Consecutive LH's and LL's About to fall off of the MA cloud Targeting the green blockShortby cdelrosa419Jan 24, 20191
the island reversal seems to be a major down signal the island reversal seems to be a major down signal the Down channel starting at the gp up matching with the gap down continues to provide the channel down peak and the centre of the channel has clustering and smaller gaps in it short at the top of this channel NShortby G13ManUpdated Jan 21, 2019442
ABBV short OpportunityFailed attempted to break - back below resistance and heading for support. NShortby HighnLowsUpdated Jan 3, 2019226
ABBV Be careful Potential Complete Zone of Cypher/SharkABBV Be careful Potential Complete Zone of Cypher/Shark Market : ABBV Time Frame: 1hr Pattern Template : Cypher / Shark Pattern Predicted Direction: Short ABBV updates will be available in the comments section below. The brief trade analysis presented above is my predicted direction and requires multiple different indicators and confluence factors prior to validating a trade opportunity. NShortby erbeUpdated Jan 2, 2019221
ABBVSo... Good news- 13.12.2018. Look like double bottom, but, tops are down,down and more down.. We will se.. Nby MarinelaDec 16, 20180
AbbVie Announces $5 Billion Increase to Stock Repurchase ProgramABBV: AbbVie 2018-12-13 13:00:00 AbbVie Announces $5 Billion Increase to Stock Repurchase ProgramNLongby JetEquitiesDec 13, 20180
ABBV Potential Monthly Breakout 35% upside to previous high, with Target 2 at $150NLongby TradingMulaDec 2, 20184
AbbVie drops below short-term trendlineAbbVie shares are likely to drop further as its short-term trend line has been broken...NShortby HamishMaertensNov 23, 20182
AbbVie: exciting moment!AbbVie shares are set to turn or break. Exciting moment! Extra bear sentiment below 87 dollar. For now, I am at the long side ($ 80).NLongby HamishMaertensNov 19, 20183
$ABBV - confirmed IHS + trend reversal Sure looks like it is ready to continue higher. NLongby random.traderNov 18, 20184
ABBV - Potential Reversal coming 2019ABBV has been losing some value in their stock since January 2018.. Some trends we can see on the chart, are a couple fibonacci patterns, farthest on left is since the stock started, and closer on the right side is the latest dip on. The retrace has hit the long term 50% Fibonacci level and bounced off. Volume has been low, however. We draw trend lines and see a falling wedge pattern developing. This will usually call for a reversal, and we can start to use a couple other indicators as well. We can use Fibonacci retrace levels to assume when downward trend may hit major resistance. We can draw in our Moving Averages for future glimpses, and also take a look at RSI for selling volume, as the stock price falls. This is one I will be keeping my eye on, as we beak into 2019. I believe ABBV has good earnings potential, has a good dividend, and overall is a strong company. Being a Daily chart, we will be looking further down the road for this to play out. Smaller patterns will develop and play out before this may happen. Look for breakout of current trends to make any moves. I marked this chart as SHORT (short term only). I find it confusing when making a LONG call on longer term charts, while knowing the stock price is still expected to dip short term.NShortby ShwayzeNov 15, 20183
Another stock in trouble. Nice short entryHey As you can see its testing Key Resistance. Descending triangle. Negative divergence, Negative Cash Flow... NShortby avka81Updated Nov 11, 2018443
AbbVie Announces Positive Results from CLL14ABBV: AbbVie 2018-10-31 16:14:00 AbbVie Announces Positive Results from CLL14, a Phase 3 Trial Evaluating a Venetoclax Combination as First-Line Therapy with a Fixed Duration of Treatment in Patients with Chronic Lymphocytic LeukemiaNLongby RocketTickersNov 1, 20181
ABBVIE - Technical AnalysisDear Traders, ABBVIE looks to be on the edge for a breakout, the MACD shows a Bullish Hidden Divergence which backs-up my LONG position. Any thoughts ? About Abbvie: AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products. It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL. NLongby Raw_BlitzUpdated Oct 3, 20182
AbbVie Announces Patient-Reported Outcomes Data from Three PivotABBV: AbbVie 2018-09-13 06:20:00 AbbVie Announces Patient-Reported Outcomes Data from Three Pivotal Phase 3 Studies of Risankizumab, Showing Significant Improvements in Health-Related Quality of Life for Patients with PsoriasisNLongby RocketTickersSep 13, 20182
Defense is favored atleast right now #ABBVAscending triangle breakout will be bullish for ABBV. Things going for ABBV have been lot of insider buying. If it breaks out, will add moreNLongby Sid1027Updated Sep 7, 20183